Amicus Therapeutics, Inc. (FOLD)
14.36
+0.00%
Amicus Therapeutics, Inc. (FOLD) is currently trading at $14.36. This represents a gain of 0% from the previous session. With a market capitalization of $4.51B, FOLD is a key component of the Health Care sector. Investors looking to trade FOLD should compare margin rates and options platforms to optimize their portfolio management.
Broker Promotion
Claim Your $300 Cash Bonus →
T&Cs Apply. Trade FOLD commission-free.
Trading Platform Comparison
Moomoo
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Good for small traders
IBKR
- Min Deposit: $0
- Commissions: $0–$0.005/share
- Fractional Shares: ✅
- Options: ✅
- Notes: Professional-level tools
Ameritrade
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Strong research tools
Webull
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Easy mobile app
AI Market Sentiment
As of today, Amicus Therapeutics, Inc. (FOLD) shows a bullish trend. Analysts are watching the 14.36 level closely.
Fundamentals
Mkt Cap4.51B
P/E Ratio0.0000
Volume410
60-Day Technical Chart
Advanced Charting
Need more indicators for FOLD? Use the world's #1 platform.
Open FOLD on TradingView →Charting Platforms
TradingView
Advanced charts & indicators, web & mobile
StockCharts
Technical analysis charts with overlays & indicators
BarCharts
Market data, charts, and technical signals
Finviz
Visual stock charts & heatmaps
Yahoo Finance Charts
Basic interactive charts with indicators
Side-by-Side: Stocks Near $14
| Metric |
FOLD +0.00% |
SMR +0.00% |
SRZN +2.56% |
HIMS +0.00% |
|---|---|---|---|---|
| Price | $14.36 | $13.43 | $14.00 | $15.46 |
| Mkt Cap | $4.51B | $4.07B | $0.12B | $3.52B |
| - | View → | View → | View → |
Latest Headlines
Stifel raises BioMarin stock price target to $68 on Fold deal value
Investing.com • Feb 24, 2026
Hut 8 Stock Before Q4 Earnings Release: Should You Hold or Fold?
Zacks Investment Research • Feb 23, 2026
Amicus Therapeutics (FOLD) Soars to 52-Week High on ‘Strong Buy’ Reco
Yahoo Finance • Dec 13, 2025
MercadoLibre Set to Report Q4 Earnings: Hold or Fold the Stock?
TradingView • Feb 20, 2026
Amicus Therapeutics (FOLD) Stock News Today: DMX-200 Trial Milestone, 52-Week High Momentum, and Analyst Forecasts (Dec. 15, 2025)
TechStock² • Dec 15, 2025
● Gemini Agentic AI Analyst Insight for FOLD
Market Education
- 🔥 Top 7 AI Penny Stocks That Could Explode in 2025 Nov 16, 2025
- What Wolves Can Teach Us About Winning in the Markets Sep 8, 2025
- Understanding Hedge Fund Alpha and Beta: A Guide for New Investors Jun 2, 2024
External Research